Cyclophosphamide as Graft-versus-host Prophylaxis After Allogeneic Stem Cell Transplantation for Multiple Myeloma
Clinical trial NCT03700450 · COMPLETED
Trial details
- NCT number
- NCT03700450
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-16
- Primary completion
- 2022-11-22
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.